nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: Real life

被引：0
|
作者：
Cidon, E. Una [1 ]
Alonso, P. [2 ]
机构：
[1] Royal Bournemouth & Christchurch Hosp NHS Fdn Tru, Bournemouth, Dorset, England
[2] Clin Univ Hosp, Valladolid, Spain
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.04.143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-61
引用
收藏
页码：S109 / S109
页数：1
相关论文
共 50 条
  • [21] Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
    Ana Fernández
    Mercedes Salgado
    Adelaida García
    Elvira Buxò
    Ruth Vera
    Jorge Adeva
    Paula Jiménez-Fonseca
    Guillermo Quintero
    Cristina Llorca
    Mamen Cañabate
    Luis Jesús López
    Andrés Muñoz
    Patricia Ramírez
    Paula González
    Carlos López
    Margarita Reboredo
    Elena Gallardo
    Manuel Sanchez-Cánovas
    Javier Gallego
    Carmen Guillén
    Nuria Ruiz-Miravet
    Víctor Navarro-Pérez
    Juan De la Cámara
    Inmaculada Alés-Díaz
    Roberto Antonio Pazo-Cid
    Alberto Carmona-Bayonas
    BMC Cancer, 18
  • [22] Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
    Fernandez, Ana
    Salgado, Mercedes
    Garcia, Adelaida
    Buxo, Elvira
    Vera, Ruth
    Adeva, Jorge
    Jimenez-Fonseca, Paula
    Quintero, Guillermo
    Llorca, Cristina
    Canabate, Mamen
    Jesus Lopez, Luis
    Munoz, Andres
    Ramirez, Patricia
    Gonzalez, Paula
    Lopez, Carlos
    Reboredo, Margarita
    Gallardo, Elena
    Sanchez-Canovas, Manuel
    Gallego, Javier
    Guillen, Carmen
    Ruiz-Miravet, Nuria
    Navarro-Perez, Victor
    De la Camara, Juan
    Ales-Diaz, Inmaculada
    Antonio Pazo-Cid, Roberto
    Carmona-Bayonas, Alberto
    BMC CANCER, 2018, 18
  • [23] A multicenter retrospective study of gemcitabine plus nab-paclitaxel or FOLFIRINOX in metastatic pancreatic cancer: NAPOLEON study
    Nakazawa, J.
    Otsuka, T.
    Shimokawa, M.
    Koga, F.
    Ueda, Y.
    Otsu, S.
    Arima, S.
    Fukahori, M.
    Makiyama, A.
    Taguchi, H.
    Honda, T.
    Shibuki, T.
    Shirakawa, T.
    Mitsugi, K.
    Nio, K.
    Ide, Y.
    Ureshino, N.
    ANNALS OF ONCOLOGY, 2019, 30
  • [24] Vitamin D receptor agonist paricalcitol plus gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer
    Perez, Kimberly
    Cleary, James M.
    Karasic, Thomas Benjamin
    Raghavan, Srivatsan
    Rahma, Osama E.
    Nowak, Jonathan
    Borazanci, Erkut Hasan
    Downes, Michael
    Drebin, Jeffrey A.
    Tuveson, David A.
    Ting, David Tsai
    Moffitt, Richard
    Yeh, Jen Jen
    Aguirre, Andrew
    Evans, Ronald
    Von Hoff, Daniel D.
    Odwyer, Peter J.
    Wolpin, Brian M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [25] Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer
    Rapposelli, Ilario Giovanni
    Casadei-Gardini, Andrea
    Vivaldi, Caterina
    Bartolini, Giulia
    Bernardini, Laura
    Passardi, Alessandro
    Frassineti, Giovanni Luca
    Massa, Valentina
    Cucchetti, Alessandro
    BIOMOLECULES, 2021, 11 (06)
  • [26] Retrospective analysis of institutional outcomes with FOLFIRINOX versus nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer
    Singh, Amisha
    Shroff, Rachna T.
    McBride, Ali
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [27] FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer
    Ay, Seval
    Atci, Muhammed Mustafa
    Arikan, Rukiye
    Dulgar, Ozgecan
    Ozyukseler, Deniz Tataroglu
    Paksoy, Nail
    Dogan, Izzet
    Oztosun, Bugra
    Tastekin, Didem
    Oven, Basak Bala
    Gumus, Mahmut
    JOURNAL OF CHEMOTHERAPY, 2022, 34 (07) : 465 - 471
  • [28] Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer
    Chiorean, E. Gabriela
    Von Hoff, Daniel
    Wan, Yin
    Margunato-Debay, Sandra
    Botteman, Marc
    Goldstein, David
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1389 - 1396
  • [29] Efficacy of Nab-Paclitaxel Plus Gemcitabine and Prognostic Value of Peripheral Neuropathy in Patients with Metastatic Pancreatic Cancer
    You, Min Su
    Ryu, Ji Kon
    Choi, Young Hoon
    Choi, Jin Ho
    Huh, Gunn
    Paik, Woo Hyun
    Lee, Sang Hyub
    Kim, Yong-Tae
    GUT AND LIVER, 2018, 12 (06) : 728 - 735
  • [30] Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
    E Gabriela Chiorean
    Daniel D Von Hoff
    Josep Tabernero
    Robert El-Maraghi
    Wen Wee Ma
    Michele Reni
    Marion Harris
    Robert Whorf
    Helen Liu
    Jack Shiansong Li
    Victoria Manax
    Alfredo Romano
    Brian Lu
    David Goldstein
    British Journal of Cancer, 2016, 115 : 188 - 194
12345